CureVac

We are thrilled to have been recognized by LexisNexis as a “Top 100 Global Innovator” for 2025 🏆 It is an honor to be part of such prestigious list of companies driving innovation, and – excitingly – it marks the third consecutive year of our inclusion on it.   To determine the list, LexisNexis analyzed companies around the globe based on their respective patent portfolio improvements. At CureVac, we are proud to have created one of the most robust intellectual property portfolios that exists today in mRNA technology.   Please find more information in our press release today announcing this recognition: https://lnkd.in/eVSp7Xyq   #Top100Innovators #InnovationMomentum #mRNA #Biotech

Happy International Day of Women and Girls in Science! Today, we honor the many talented women across the globe who have made contributions to the advancement of science.   This day also gives us an opportunity to acknowledge the importance of promoting science education for girls and ensuring equal opportunity for young women who want to pursue careers in this broad and ever-critical field.   We connected with some of our own esteemed scientists – Janina Gergen, Janine Mühe, and Kristina Kovacikova – who offered some wonderful perspectives as well as great advice for women and girls hoping to break into the sciences.   See what they have to say!   #WomenInScience #STEM #mRNA #Biotech

A diagnosis of cancer is life changing.   World Cancer Day gives us all an opportunity to not only raise awareness of cancer but also recognize the many individuals who have been or are currently impacted by it.   With such a vast disease area, new innovation in medicine is a critical component to securing a healthier and brighter future for patients. In our oncology work at CureVac, we are leveraging mRNA with an aim to one day change health outcomes in glioblastoma.   So today we share the image of a ribbon in grey – the awareness color for brain cancer – in support the many individuals battling this devasting form of disease.   #WorldCancerDay #WorldCancerDay2025 #mRNA #Cancer #HealthcareInnovation #Glioblastoma

We greatly look forward to participating in the 4th Annual mRNA-Based Therapeutics Summit Europe in Frankfurt, Germany this week! And we have quite the lineup there…   Kicking off the conference, our CEO Dr. Alexander Zehnder, MD, MBA, alongside other notable life science leaders, will join a group panel set to discuss the exciting future opportunities in the field of mRNA.   Our CSO Dr. Myriam Mendila will present on current strategies for the development of cancer vaccines as well as share encore data from CureVac’s Phase 1 study of our cancer vaccine candidate (CVGBM) in patients with resected glioblastoma.   And Dr. Ulrike Jaegle, CureVac Vice President of Global Regulatory Affairs & Preclinical Safety, will be on panel exploring the regulatory landscape as it applies to mRNA medicines.   We hope to see you there!   You can find more details on the event here https://ter.li/welq6g   #mRNA #Cancer #Oncology #Glioblastoma #HealthcareInnovation #biotech

https://lnkd.in/e7KmB-F6

Honored to have been selected as a Top Employer 2025 by the Top Employers Institute 🏆 This marks the third consecutive year that we’ve been awarded this special certification. At CureVac, we’re very proud of the high standards we’ve established and that we continue to evolve when it comes to ensuring a positive employee experience. #TopEmployer2025 #TopEmployers2025 #CompanyCulture #HR

The start of the 43rd Annual J. P. Morgan Healthcare Conference is just around the corner! If you’d like to meet with members of our leadership team while in San Francisco next week, please reach out to the Precision AQ team to schedule a 1x1 meeting: https://lnkd.in/gEsWCVhj   The potential of mRNA to take medicine to the next level is something that inspires our team at CureVac every day to continue to innovate and explore. We’re particularly excited to enter 2025 with our recently expanded pipeline spanning a variety of indications.   Be sure to connect with us at JPM!   #JPM2025 #HealthcareInnovation #mRNA #JPM #Biotech #Medicine

🎇With 2025 right around the corner, we wanted to take a moment to reflect on some of our most important milestones over the course of this past year🎇   We are immensely grateful to our entire team – the #RNAPeople – for working hard to drive forward our mission, and we want to celebrate our collective accomplishments with this short clip below of some of CureVac’s biggest 2024 moments!   #mRNA #Teamwork #HealthcareInnovation #Biotech #HappyNewYear

✨It was wonderful to have the opportunity to offer support to two different local charities in CureVac’s hometown Tübingen this holiday season✨   In addition to recently making a donation to The Support Association for Children with Cancer Tübingen (Förderverein für krebskranke Kinder Tübingen e.V.), we also participated in the  event called Päckchenengel (Package Angel Campaign). For this event, our team got together to fill CureVac-designed holiday boxes with presents and gifts for Tübingen children and older women in need.   A huge “thank you” to these Tübingen organizations for their continued efforts to make a difference in people’s lives in this community. Also a big thank you "thank you" to all of our RNA people who filled the holiday boxes with such great commitment.   Check out some pictures below of the handover of the donation and the fun present boxes we made!   #Community #CommunitySupport #GiveBack

✨🎉We could not possibly close out the year without a festive gathering as a team to celebrate all the many successes we’ve achieved together.   Our 2024 Holiday Party was one to remember – and while the atmosphere and décor were certainly a perk of the evening, having fun and spending time with our fantastic team was undoubtedly the main highlight.   A huge thanks to our #RNAPeople for all their hard work and commitment to transforming the future of medicine.   Check out some pictures from the party below!   #Teamwork #mRNA #biotech